Single and Multiple Ascending Dose Study of NGM120 in Healthy Adult Subjects

A Phase 1 Randomized, Double Blind, Placebo Controlled, Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of NGM120 in Healthy Adult Subjects

The purpose is to evaluate the safety, tolerability, and PK of NGM120 in healthy adult subjects

Inclusion Criteria:

• Normal ECG findings

Exclusion Criteria:

• Significant history or clinical manifestation of any allergic, dermatological, hepatic, renal, hematological, pulmonary, metabolic, cardiovascular, gastrointestinal, neurological, or psychiatric disorder